CLINICAL_TRIALS
trial_result
· 2013-12-06
Clinical Trial Update: Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD) [Phase 3]
Summary
A Phase 3 study evaluating orBec in combination with prednisone for graft-versus-host disease was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Soligenix | Conditions: Acute Gastrointestinal Graft vs Host Disease | Phase 3 | Status: TERMINATED | Results posted: 2013-12-06